Invest Concierge

Compensation

Full Description

Join the inner circle of accredited investors and strategic advisors for N21.AI — a biotech + AI-driven startup building next-gen diagnostic and therapeutic platforms. N21.AI seeks experienced physicians, biotech executives, strategic thinkers, and accredited investors who want hands-on early access. Members of this circle serve both as advisors shaping direction and early backers positioned to benefit as N21.AI scales. This structure — combining advisory insight + early investment option — offers a rare alignment: you guide value creation and share in upside from that early ground floor. What’s Going On at N21.AI (Stealth Mode – Early Traction Underway) • Founding team includes seasoned biotech & AI engineers with multiple prior exits and top-tier credentials. • Early internal milestones achieved: proof-of-concept in diagnostic AI module; data-pipeline infrastructure built; early outreach to clinical partners underway. • Raised seed capital from private network (non-dilutive grants + founder capital), enabling core development without aggressive dilution or external pressure. • Patent filings & IP preparations under way — positioning N21.AI to enter regulatory/clinical stages within 12–18 months. What Accredited Advisors Receive (If Selected) • Private Strategy Briefings with N21.AI’s founder & core team • Early-Access to Deal Materials — including pipeline roadmap, product demos, and future funding plans • Invitation to Strategic Advisory Board — contribute to go-to-market, regulatory strategy, clinical partnerships, or product design • Optional Investor Slot — early access to raise (e.g., $25,000+) when the next round opens; ability to invest via personal funds or rollover-eligible IRAs/401(k)s (if applicable) • Priority Access to Founder Dinners / Small-Group Sessions — meet other early investors, network, and stay aligned on growth Who This Is For • Experienced healthcare professionals: physicians, scientists, regulatory, biotech operations • Accredited investors with interest in biotech, AI, diagnostics, or frontier medical technologies • Strategic operators, entrepreneurs, or advisors who understand regulatory cycles and value early positioning • Individuals comfortable with early-stage risk for high asymmetric upside How to Apply / Get More Info • Submit interest via Invest Concierge (LinkedIn or official submission form) • Initial screening to confirm accreditation and background fit • NDA → Introductory call / virtual briefing with founder and core team • If aligned → Invitation to advisory-investor circle; receive deal materials + early access No public offering, no public solicitation. This is a private, curated offering for qualified individuals. Why We’re Doing It This Way N21.AI is in a foundational stage — building diagnostic & therapeutic infrastructure, securing IP, and preparing for clinical/market entry. We believe that having strategic advisors who also invest aligns incentives: you help us build right, early; you benefit if we succeed. Because we are still early and steering carefully, this invitation-only model protects confidentiality, ensures quality, and aligns long-term vision for both founders and early supporters. If you are interested in shaping the future of biotech + AI and want early access to a high-potential startup — we welcome your inquiry.